Preventive and curative treatment of priapism in sickel cell disease;Prevention et traitement des troubles erectiles de la drepanocytose

Revue de Medecine Interne

Volumn 18, Issue SUPPL. 1, 1997, Pages

  Bachir, D ^a   Virag, R ^b   Lee, K ^a   Belloy, M ^c   De Montalembert, M ^d   Denis, L ^a   Broyart, A ^f   Girot, R ^e   Galacteros F ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b CETI   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔPITAL TENON   (France)

^f NONE

Author keywords

etilefrine; impotence; intracavernous injections; priapism; sickle cell disease; agonists

Indexed keywords

ETILEFRINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CORPUS CAVERNOSUM; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PRIAPISM; SICKLE CELL ANEMIA; ADOLESCENT; ADULT; CHILD; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REVIEW; SICKLE CELL TRAIT; TIME;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; CHILD; CHILD, PRESCHOOL; ETILEFRINE; HUMANS; MALE; PRIAPISM; SICKLE CELL TRAIT; TIME FACTORS;

EID: 0030998956     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)82715-4     Document Type: Article

References (17)

1. Bachir D, Galacteros F, Goldcher A. La drépanocytose. Dossier du Praticien. Impact Médecin 1995;291:III-XV
2. Virag R. About pharmacologically induced prolonged erection. Lancet 1985;2:519-20
3. Hakim SL, Hashmat IA, Macchia RJ. In: Priapism, Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease Basic Principles and Clinical Practice. New York: Raven Press, 1994:633-43
4. Ramos CE, Park JS, Ritchey ML, Benson GS. High flow priapism associated with sickle cell disease. J Urol 1995;163:1619-21
5. Miller ST, Rao PR, Glassberg KI. Priapism in children with sickle cell disease. J Urol 1995;154:844-7
6. Chakrabarty A, Upadhyay J, Dhabuwala CB. Sarnaik S, Perlmutter AD, Connor JP. Priapism associated with sickle cell hemoglobmopathy in children : long-term effects on potency. J Urol 1996;155:1419-23
7. Serjeant GR. Priapism. In: Sickle cell disease (2nd ed). Oxford: University Press, 1992:282-91
8. Hamre MR, HarmonEP, KirkpatrickDV, Stern MJ, Humbert JR. Priapism as a complication of sickle cell disease. J Urol 1991; 145:1-5
9. Sharpsteen JR, Powars D, Johnson C, Rogers ZR, Williams WD, Posch RJ. Multisystem damage associated with Incorporeal priapism in sickle cell disease. Am Med 1993;94:289-95
10. Fowler JE, Koshy M. Strub M, Chinn SK. Priapism associated with sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991;145:65-8
11. Mykulak DJ, Glassberg KI. Impotence following childhood priapism. J Urol 1991;144:135-9
12. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980;140:1434-7
13. Virag R, Bachir D, Lee K. Galacteros F. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology 1996;47:777-81
14. Cavender JD, Ewalt D, Rogers Z, Buchanan GR. Treatment of severe priapism in young patients with sickl cell disease with oral or intrapenile adrenergic agonists. Program of the 20th Annual Meeting of the National Sickle Cell Disease Society. Boston: March 18-21, 1995:147 [Abstract]
15. Serjeant GR, de Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 1985;2:1274
16. Levine LA, GUSS SP. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol 1993;150:475-7
17. Linet OI, Neff LL. Intracavernous prostaglandin El in erectile dysfunction. Clin Invest 1994;72:139-49